Combinatorial in situ cancer vaccines: unlocking broad and enhanced antitumor responses
Recent advances in nanomedicine-enabled delivery systems, microenvironmental modulation, and combinatorial strategies are overcoming challenges and position in situ cancer vaccination as a patient-tailored, broadly applicable immunotherapy capable of eliciting durable and systemic antitumor immunity.